In gastric cancer, it promotes cisplatin resistance as a consequence of apoptosis, autophagy, and ferroptosis inhibition by abolishing the regulatory power of miR-508-3p on the ↑Bcl-2/beclin1/SLC7A11 axis (37). Here, BECN1 is linked to gastric cancer.